Natco Pharma has received tentative approval from United States Food & Drug Administration (USFDA) for Oseltamivir Phosphate Capsules USP, 30 mg (base), 45 mg (base) and 75 mg (base). The company has partnered with Alvogen for marketing.
For more information ✆ - 0731-6642300 or Visit http://ift.tt/1doLhaI
0 comments:
Post a Comment